These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4555591)

  • 1. Controlled studies in clinical cancer research.
    Chalmers TC; Block JB; Lee S
    N Engl J Med; 1972 Jul; 287(2):75-8. PubMed ID: 4555591
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonal treatment of cancer of the prostate: review and present status].
    Ganzer R; Wieland WF; Bach T; Rössler W; Blana A
    Dtsch Med Wochenschr; 2007 Jan; 132(4):161-6. PubMed ID: 17230333
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase I cancer trials: therapeutic research?
    Wells RJ
    Hastings Cent Rep; 2001; 31(1):4; author reply 5. PubMed ID: 11478096
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I cancer trials: therapeutic research?
    Kodish E
    Hastings Cent Rep; 2001; 31(1):4-5. PubMed ID: 11478093
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-randomized controls in cancer clinical trials.
    Gehan EA; Freireich EJ
    N Engl J Med; 1974 Jan; 290(4):198-203. PubMed ID: 4587632
    [No Abstract]   [Full Text] [Related]  

  • 7. L-asparaginase; a new type of anticancer drug.
    Livingston BM; Krakoff IH
    Am J Nurs; 1970 Sep; 70(9):1910-5. PubMed ID: 4914184
    [No Abstract]   [Full Text] [Related]  

  • 8. The conduct of therapeutic trials in cancer medicine.
    Rudnick S; Capizzi RL
    Semin Oncol; 1977 Jun; 4(2):255-8. PubMed ID: 327556
    [No Abstract]   [Full Text] [Related]  

  • 9. [The outcome of prostatic cancer treated with estrogens].
    Claereboudt E; Vanwelkenhuyzen P
    Acta Urol Belg; 1973 Jul; 41(3):427-31. PubMed ID: 4751698
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of malignant tumors].
    Ehrhart H
    Munch Med Wochenschr; 1973 May; 115(18):814-32. PubMed ID: 4800214
    [No Abstract]   [Full Text] [Related]  

  • 11. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge yet close to home. Cancer research in the community.
    Fessele KL
    ONS Connect; 2008 Dec; 23(12):10-4. PubMed ID: 19093339
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings of the Symposium on Designs for Clinical Cancer Research. Discussion II: Critical definitions and criteria for evaluation.
    Cancer Treat Rep; 1980; 64(2-3):469-71. PubMed ID: 7407786
    [No Abstract]   [Full Text] [Related]  

  • 14. Dying for a cure. Why cancer patients often turn to risky, experimental treatments--and wind up paying with their lives.
    Kaplan S; Brownlee S
    US News World Rep; 1999 Oct; 127(14):34-7, 40-3. PubMed ID: 10621514
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytostatic therapy of prostatic carcinoma. Current status and personal results].
    Nagel R; Leistenschneider W
    Urologe A; 1983 Sep; 22 Suppl():304-9. PubMed ID: 6356555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical trial.
    Chalmers TC
    Milbank Mem Fund Q Health Soc; 1981; 59(3):324-39. PubMed ID: 7024846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of malignant tumors].
    Kredel L; Tittor W
    Hippokrates; 1975 Aug; 46(3):333-51. PubMed ID: 770399
    [No Abstract]   [Full Text] [Related]  

  • 18. Ongoing phase II & III studies of the USA National Prostatic Cancer Project.
    Elder JS; Gibbons RP
    Prog Clin Biol Res; 1985; 185A():427-34. PubMed ID: 3898135
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adjuvant hormone therapy in prostatic cancer: after treatment with curative intent. The viewpoint of the urologist].
    Martorana G
    Recenti Prog Med; 2002 Mar; 93(3):179-82. PubMed ID: 11942170
    [No Abstract]   [Full Text] [Related]  

  • 20. ["Androgenic shock" during treatment of prostate gland cancer].
    Religa Z
    Pol Przegl Chir; 1969; 41(4):Suppl 4a:534+. PubMed ID: 4896406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.